Variant report

Variant	esv3336485
Chromosome Location	chr6:43730848-43733789
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:28)
CpG islands
(count:61)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:28 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr6:43731121-43731427	IMR90	lung:	n/a	n/a
2	CTCF	chr6:43731060-43731210	HAc	cerebellar:	n/a	n/a
3	CTCF	chr6:43730980-43731130	AG04449	skin:	n/a	n/a
4	CTCF	chr6:43731071-43731093	GM12878	blood:	n/a	n/a
5	CTCF	chr6:43730980-43731130	HCPEpiC	choroid plexus:	n/a	n/a
6	CTCF	chr6:43730960-43731110	WERI-Rb-1	eye:	n/a	n/a
7	CTCF	chr6:43731120-43731270	AG09319	gingival:	n/a	n/a
8	CTCF	chr6:43731000-43731150	AG09309	skin:	n/a	n/a
9	CTCF	chr6:43731116-43731122	GM19240	blood:	n/a	n/a
10	CTCF	chr6:43730820-43730970	HRPEpiC	eye:	n/a	n/a
11	CTCF	chr6:43731077-43731089	GM19238	blood:	n/a	n/a
12	CTCF	chr6:43731100-43731250	NB4	blood:	n/a	n/a
13	CTCF	chr6:43731040-43731190	Caco-2	colon:	n/a	n/a
14	CTCF	chr6:43731020-43731170	HRPEpiC	eye:	n/a	n/a
15	CTCF	chr6:43731089-43731108	GM19240	blood:	n/a	n/a
16	CTCF	chr6:43731110-43731111	HepG2	liver:	n/a	n/a
17	CTCF	chr6:43731044-43731135	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr6:43731073-43731131	GM12891	blood:	n/a	n/a
19	CTCF	chr6:43731100-43731250	GM12874	blood:	n/a	n/a
20	CTCF	chr6:43730960-43731110	HCM	heart:	n/a	n/a
21	RCOR1	chr6:43731848-43732089	K562	blood:	n/a	n/a
22	RUNX3	chr6:43731064-43731494	GM12878	blood:	n/a	n/a
23	SPI1	chr6:43731123-43731547	HL-60	blood:	n/a	chr6:43731397-43731410
24	SPI1	chr6:43731128-43731486	GM12891	blood:	n/a	chr6:43731397-43731410
25	ZBTB7A	chr6:43731003-43731164	HepG2	liver:	n/a	chr6:43731105-43731114
26	ZNF384	chr6:43732026-43732096	K562	blood:	n/a	n/a
27	ZNF384	chr6:43731138-43731381	K562	blood:	n/a	n/a
28	ZNF384	chr6:43731124-43731431	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:43732881-43732931	RPTEC	kidney:	n/a
2	chr6:43732881-43732931	HEK293	kidney:	embryo
3	chr6:43732881-43732931	A549	lung:	n/a
4	chr6:43732881-43732931	AG10803	skin:	n/a
5	chr6:43732881-43732931	IMR90	lung:	fetal
6	chr6:43732881-43732931	HPAEpiC	pulmonary alveolar:	n/a
7	chr6:43732881-43732931	AG04449	skin:	fetal
8	chr6:43732881-43732931	ECC-1	luminal epithelium:	n/a
9	chr6:43732881-43732931	ProgFib	skin:	n/a
10	chr6:43732881-43732931	AG04450	lung:	fetal
11	chr6:43732881-43732931	HUVEC	blood vessel:	n/a
12	chr6:43732881-43732931	SKMC	muscle:	n/a
13	chr6:43732881-43732931	HRCEpiC	kidney:	n/a
14	chr6:43732881-43732931	AG09319	gingival:	n/a
15	chr6:43732881-43732931	NH-A	brain:	n/a
16	chr6:43732881-43732931	HAEpiC	amniotic membrane:	n/a
17	chr6:43732881-43732931	MCF10A-Er-Src	breast:	n/a
18	chr6:43732881-43732931	GM19239	blood:	n/a
19	chr6:43732881-43732931	HepG2	liver:	n/a
20	chr6:43732881-43732931	GM06990	blood:	n/a
21	chr6:43732881-43732931	Hela-S3	cervix:	n/a
22	chr6:43732881-43732931	PrEC	prostate:	n/a
23	chr6:43732881-43732931	SK-N-SH_RA	brain:	n/a
24	chr6:43732881-43732931	HIPEpiC	eye:	n/a
25	chr6:43732881-43732931	AG09309	skin:	n/a
26	chr6:43732881-43732931	H1-hESC	embryonic stem cell:	embryo
27	chr6:43732881-43732931	HCM	heart:	n/a
28	chr6:43732881-43732931	SK-N-MC	brain:	n/a
29	chr6:43732881-43732931	NT2-D1	testis:	n/a
30	chr6:43732881-43732931	NHBE	bronchial:	n/a
31	chr6:43732881-43732931	Jurkat	blood:	n/a
32	chr6:43732881-43732931	PANC-1	pancreas:	n/a
33	chr6:43732881-43732931	GM12878	blood:	n/a
34	chr6:43732881-43732931	ovcar-3	ovarian:	n/a
35	chr6:43732881-43732931	GM12891	blood:	n/a
36	chr6:43732881-43732931	HRPEpiC	eye:	n/a
37	chr6:43732881-43732931	SAEC	small airway:	n/a
38	chr6:43732881-43732931	NB4	blood:	n/a
39	chr6:43732881-43732931	LNCaP	prostate:	n/a
40	chr6:43732881-43732931	GM12892	blood:	n/a
41	chr6:43732881-43732931	MCF-7	breast:	n/a
42	chr6:43732881-43732931	U87	brain:	n/a
43	chr6:43732881-43732931	T-47D	breast:	n/a
44	chr6:43732881-43732931	AoSMC	blood vessel:	n/a
45	chr6:43732881-43732931	NHDF-neo	bronchial:	n/a
46	chr6:43732881-43732931	HMEC	breast:	n/a
47	chr6:43732881-43732931	K562	blood:	n/a
48	chr6:43732881-43732931	HNPCEpiC	eye:	n/a
49	chr6:43732881-43732931	HEEpiC	esophagus:	n/a
50	chr6:43732881-43732931	HL-60	blood:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:43633891..43636321-chr6:43729623..43731755,2	MCF-7	breast:
2	chr6:43730421..43734322-chr6:43919726..43923267,3	K562	blood:
3	chr6:43730164..43744120-chr6:44034600..44052665,50	K562	blood:
4	chr6:43631256..43632895-chr6:43730979..43733533,2	MCF-7	breast:
5	chr1:149223199..149225385-chr6:43731929..43733479,2	MCF-7	breast:
6	chr6:43635642..43637248-chr6:43729163..43731133,2	MCF-7	breast:
7	chr6:43732418..43734383-chr6:44067605..44069368,2	K562	blood:
8	chr6:43692844..43694589-chr6:43732603..43735639,3	MCF-7	breast:

No data

Variant related genes	Relation type
VEGFA	TF binding region
VEGFA	CpG island
ENSG00000206737	chromatin interactions
ENSG00000237686	chromatin interactions
ENSG00000231881	chromatin interactions

Extended variants
information (count: 105 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:105 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538027318	chr6:43730851-43730852	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs111650539	chr6:43730968-43730969	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs559015752	chr6:43730994-43730995	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs143613090	chr6:43730998-43730999	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs554378330	chr6:43731009-43731010	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs181669494	chr6:43731042-43731043	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs35334231	chr6:43731075-43731076	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs187131201	chr6:43731118-43731119	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs116682727	chr6:43731140-43731141	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs191950275	chr6:43731267-43731268	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs551331132	chr6:43731291-43731292	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs146506665	chr6:43731357-43731358	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs141149006	chr6:43731393-43731394	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs150134400	chr6:43731397-43731398	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs138614894	chr6:43731403-43731404	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs61654493	chr6:43731443-43731444	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs529916714	chr6:43731478-43731479	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs563096579	chr6:43731519-43731520	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs548426456	chr6:43731540-43731541	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs35454441	chr6:43731591-43731592	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs566695729	chr6:43731641-43731642	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs78003500	chr6:43731651-43731652	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs552318173	chr6:43731677-43731678	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs183379710	chr6:43731727-43731728	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs75461305	chr6:43731809-43731810	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs556262901	chr6:43731829-43731830	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs57342360	chr6:43731853-43731854	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs833058	chr6:43731854-43731855	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs186632605	chr6:43731858-43731859	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs376034304	chr6:43731937-43731938	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs189937734	chr6:43731964-43731965	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs148847491	chr6:43731990-43731991	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs143475707	chr6:43731991-43731992	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs375397259	chr6:43732001-43732002	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs576934936	chr6:43732062-43732063	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs62401161	chr6:43732096-43732097	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs79525584	chr6:43732099-43732100	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs75681205	chr6:43732115-43732116	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs550369271	chr6:43732125-43732126	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs562579206	chr6:43732178-43732179	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs138012915	chr6:43732179-43732180	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs541707230	chr6:43732196-43732197	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs560375087	chr6:43732222-43732223	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs527623889	chr6:43732237-43732238	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs143392496	chr6:43732239-43732240	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs564114694	chr6:43732244-43732245	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs568689435	chr6:43732256-43732257	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs531602039	chr6:43732277-43732278	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs145786120	chr6:43732291-43732292	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs568259945	chr6:43732296-43732297	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Ovarian cancer	21720365	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21364760	CNVD
Urothelial carcinoma	21177765	CNVD
Colorectal cancer	16790693	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Systemic lupus erythematosus	19287148	CNVD
Colorectal cancer	19359472	CNVD
Multiple myeloma	16616336	CNVD
Chordoma	18071362	CNVD
Follicular lymphoma	16790693	CNVD
Osteosarcoma	19286668	CNVD
Neurocytoma	17123091	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	21569311	CNVD
Cancer	20164920	CNVD
Bladder cancer	21909424	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD

Chromatin state (count:115 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:43709000-43737000	Weak transcription	Right Atrium	heart
2	chr6:43722000-43737400	Weak transcription	Fetal Kidney	kidney
3	chr6:43725800-43733400	Enhancers	Fetal Lung	lung
4	chr6:43726000-43731200	Weak transcription	Duodenum Mucosa	Duodenum
5	chr6:43726200-43731400	Weak transcription	Ovary	ovary
6	chr6:43727000-43731200	Weak transcription	HUES64 Cell Line	embryonic stem cell
7	chr6:43727200-43731000	Weak transcription	H1 Cell Line	embryonic stem cell
8	chr6:43727200-43733800	Bivalent Enhancer	HepG2	liver
9	chr6:43727600-43731200	Weak transcription	HUES48 Cell Line	embryonic stem cell
10	chr6:43727600-43731200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
11	chr6:43727600-43731400	Weak transcription	Stomach Mucosa	stomach
12	chr6:43727600-43737200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr6:43728000-43731800	Enhancers	Fetal Muscle Leg	muscle
14	chr6:43728600-43731000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr6:43728800-43731200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
16	chr6:43728800-43731200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr6:43729000-43731200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr6:43729200-43734600	Enhancers	Fetal Stomach	stomach
19	chr6:43729200-43737200	Weak transcription	Spleen	Spleen
20	chr6:43729600-43731200	Enhancers	Pancreas	Pancrea
21	chr6:43729800-43731800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr6:43729800-43731800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr6:43729800-43737400	Enhancers	Fetal Intestine Small	intestine
24	chr6:43730000-43731000	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr6:43730000-43731200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr6:43730000-43731400	Bivalent Enhancer	Placenta	Placenta
27	chr6:43730000-43737400	Enhancers	Fetal Intestine Large	intestine
28	chr6:43730400-43731400	Enhancers	Fetal Muscle Trunk	muscle
29	chr6:43730400-43732000	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr6:43730400-43732000	Enhancers	Osteobl	bone
31	chr6:43730400-43732400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr6:43730400-43732600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr6:43730400-43732600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr6:43730600-43731000	Enhancers	Monocytes-CD14+_RO01746	blood
35	chr6:43730600-43731200	Enhancers	Placenta Amnion	Placenta Amnion
36	chr6:43730800-43731600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr6:43730800-43731800	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr6:43730800-43732000	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr6:43730800-43732200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
40	chr6:43730800-43734000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr6:43731000-43731200	Enhancers	Cortex derived primary cultured neurospheres	brain
42	chr6:43731000-43731400	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr6:43731000-43731400	Enhancers	Primary hematopoietic stem cells	blood
44	chr6:43731000-43731600	Enhancers	Primary hematopoietic stem cells short term culture	blood
45	chr6:43731000-43731600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
46	chr6:43731000-43731800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
47	chr6:43731000-43731800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr6:43731000-43733000	Enhancers	H1 Cell Line	embryonic stem cell
49	chr6:43731200-43731400	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr6:43731200-43731400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links